Evidence map›Paper›PMID 34456367›Full record

ReviewMonatshefte fur chemie2021

An overview of chiral separations of pharmaceutically active substances by HPLC (2018-2020).

Sofiya Grybinik, Zuzana Bosakova

Erratum issuedAbstract readReview
In one paragraph

Review in Monatshefte fur chemie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sofiya GrybinikDepartment of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
Zuzana BosakovaDepartment of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.ORCID 0000-0002-8483-5739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review provides a brief survey of chiral separation of pharmaceutically active substances published over the last 3 years (2018-2020). Chiral separation of drugs is an important area of research. The control of enantiomeric purity and determination of individual enantiomeric drug molecules is a necessity especially for clinical, analytical, and regulatory purposes. Among chromatographic resolution methods, high-performance liquid chromatography based on chiral stationary phases remains the most popular and effective method used for chiral separation of various drugs. In this review, attention is paid to several classes of chiral stationary phases that have been the most frequently used for drug enantioseparation during this period. GRAPHIC ABSTRACT:

Indexed as

Chiral resolutionChiral stationary phaseHPLCPharmaceutical compounds

Identifiers

PMID34456367
PMCPMC8382579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.